Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice

Acute graft-versus-host disease (aGVHD) is the second most common cause of death after allogeneic hematopoietic stem cell transplantation (allo-HSCT), underscoring the need for novel therapies. Based on previous work that endothelial cell dysfunction is present in aGVHD and that epidermal growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorrance, Adrienne M., Moutuou, Moutuaata M., Goda, Chinmayee, Sell, Natalie E., Kalyan, Sonu, Karunasiri, Malith, Kulkarni, Rohan, Goulard, Marie, Kolovich, Sofia, Rudich, Alexander, Naumann, Eric, Ackaoui, Antoine, Bigras, Charles-Etienne, Daudelin, Francis, Garzon, Ramiro, Ranganathan, Parvathi, Guimond, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Stimulus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006300/
https://www.ncbi.nlm.nih.gov/pubmed/34654057
http://dx.doi.org/10.1182/bloodadvances.2021005498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006300/
https://www.ncbi.nlm.nih.gov/pubmed/34654057
http://dx.doi.org/10.1182/bloodadvances.2021005498

Ejemplares similares